Genomatix Software GmbH today announced that it has achieved GeneChip-compatibleTM
status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip microarray platform and that it has joined Affymetrix GeneChip-compatible Applications Program, which provides customers with a broad spectrum of software solutions for biomedical research and development. As a GeneChip-compatible software provider, Genomatix is committed to seamlessly integrating its entire microarray analysis pipeline with the Affymetrix technology.
The Genomatix line of products which achieved GeneChip-compatibleTM status consists of ChipInspector, ChipInspector TL, ElDorado, GEMS Launcher, and BiblioSphere PathwayEdition. With those products Genomatix provides a broad set of solutions for Affymetrix GeneChip users, including analysis of data from Affymetrix whole-genome tiling and exon arrays.
"We are proud of having met the high standards of Affymetrix and earning GeneChip-compatibleTM status. The tight integration of our microarray analysis pipeline with the Affymetrix platform will stimulate exciting new results in both basic and applied biomedical R&D," said Klaus May, Director of Sales and Marketing at Genomatix. "Especially in conjunction with the new Affymetrix tiling and exon array technology, I expect that our tools will drive far greater understanding of genomic organization and transcriptome regulation."
"Affymetrix is pleased to be working with Genomatix in their efforts to develop advanced tools for analyzing GeneChip data," said Steve Lincoln, vice president of Informatics at Affymetrix. "We are particularly excited to see the emergence of next-generation commercial software which can help bring unprecedented levels of genomic resolution into the hands of applied biomedical researchers."
Page: 1 Related biology news :1
Contact: Klaus May
Genomatix Software GmbH
. Genomatix expands operations in North America2
. Application of Genomatix in silico methods reveals novel cancer associated genes3
. Genomatix and Molecular Connections form strategic partnership4
. Genomatix wins BioChance grant worth $1.6 million5
. Genomatix appoints distributor for the growing Chinese market6
. MatBase -- A new transcription factor knowledge base released by Genomatix7
. The Center of Nutrigenomics of the TU Munich licences Genomatix Microarray Analysis Pipeline8
. Bayer HealthCare licenses Genomatix for microarray analysis9
. Genomatix technology facilitates de novo identification of new renal disease associated genes10
. Genomatix partners with Research Instruments Pte Ltd for Singapore, Malaysia and Thailand markets11
. German Microarray Excellence Center integrates Genomatix Chip Analysis Pipeline